Skip to main content

Table 1 Somatostatin receptorsa in neuroendocrine gastroenteropancreatic tumours [%]

From: Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives

 

SSTR1

SSTR2

SSTR3

SSTR4

SSTR5

All

68

86

46

93

57

Insulinoma

33

100b

33

100

67

Gastrinoma

33

50

17

83

50

Glucagonoma

67

100

67

67

67

VIPoma

100

100

100

100

100

N-F

80

100

40

100

60

  1. VIP, vasoactive intestinal polypeptide; N-F, Non functioning; aUsing receptor subtype antibodies; bMalignant insulinoma
  2. [Modified from Oberg K, Annals of Oncology, 2004]
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us